These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37385455)

  • 1. Delivery of chiral D-cysteine by pH-responsive mesoporous silica nanoparticles for effective bacterial inhibition.
    Ye Z; Qian J; Zhang J; Yan W
    J Microbiol Methods; 2023 Aug; 211():106776. PubMed ID: 37385455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of selenium-embedded mesoporous silica with improved antibacterial activity.
    Chen J; Wei Y; Yang X; Ni S; Hong F; Ni S
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110910. PubMed ID: 32126358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting antibacterial activity with mesoporous silica nanoparticles supported silver nanoclusters.
    Liu J; Li S; Fang Y; Zhu Z
    J Colloid Interface Sci; 2019 Nov; 555():470-479. PubMed ID: 31400539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms.
    Lu MM; Ge Y; Qiu J; Shao D; Zhang Y; Bai J; Zheng X; Chang ZM; Wang Z; Dong WF; Tang CB
    Int J Nanomedicine; 2018; 13():7697-7709. PubMed ID: 30538453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of mesoporous silica/hydroxyapatite loaded quercetin nanoparticles and research on its antibacterial properties.
    Yi X; Bao F; Fu S; Yang Y; Xu Y
    Med Eng Phys; 2024 Apr; 126():104160. PubMed ID: 38621842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant
    Memar MY; Yekani M; Ghanbari H; Shahi S; Sharifi S; Maleki Dizaj S
    Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1354-1361. PubMed ID: 33236938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Inhibition of Drug-Resistant
    Ye Z; Wang S; Xu Y; Zhang J; Yan W
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria.
    Memar MY; Yekani M; Farajnia S; Ghadiri Moghaddam F; Nabizadeh E; Sharifi S; Maleki Dizaj S
    Arch Microbiol; 2023 Mar; 205(4):109. PubMed ID: 36884153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers.
    Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW
    Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface pH buffering to promote degradation of mesoporous silica nanoparticles under a physiological condition.
    Choi E; Kim S
    J Colloid Interface Sci; 2019 Jan; 533():463-470. PubMed ID: 30172772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles as carrier to overcome bacterial drug resistant barriers.
    Zhuang J; Yu Y; Lu R
    Int J Pharm; 2023 Jan; 631():122529. PubMed ID: 36563796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using "graft to" strategy for drug controlled release.
    Mu S; Liu Y; Wang T; Zhang J; Jiang D; Yu X; Zhang N
    Acta Biomater; 2017 Nov; 63():150-162. PubMed ID: 28873341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial and biodegradable tissue nano-adhesives for rapid wound closure.
    Lu MM; Bai J; Shao D; Qiu J; Li M; Zheng X; Xiao Y; Wang Z; Chang ZM; Chen L; Dong WF; Tang CB
    Int J Nanomedicine; 2018; 13():5849-5863. PubMed ID: 30310284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo.
    Li LL; Wang H
    Adv Healthc Mater; 2013 Oct; 2(10):1351-60. PubMed ID: 23526816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.